Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism Y Ueki, V Tiziani, C Santanna, N Fukai, C Maulik, J Garfinkle, C Ninomiya, ... Nature genetics 28 (2), 125-126, 2001 | 421 | 2001 |
NFATc1 in mice represses osteoprotegerin during osteoclastogenesis and dissociates systemic osteopenia from inflammation in cherubism AO Aliprantis, Y Ueki, R Sulyanto, A Park, KS Sigrist, SM Sharma, ... The Journal of clinical investigation 118 (11), 3775-3789, 2008 | 391 | 2008 |
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK E Reichenberger, V Tiziani, S Watanabe, L Park, Y Ueki, C Santanna, ... The American Journal of Human Genetics 68 (6), 1321-1326, 2001 | 216 | 2001 |
Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism N Levaot, O Voytyuk, I Dimitriou, F Sircoulomb, A Chandrakumar, ... Cell 147 (6), 1324-1339, 2011 | 202 | 2011 |
Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 “cherubism” mice Y Ueki, CY Lin, M Senoo, T Ebihara, N Agata, M Onji, Y Saheki, T Kawai, ... Cell 128 (1), 71-83, 2007 | 197 | 2007 |
Organization and expression of basement membrane collagen IV genes and their roles in human disorders Y Sado, M Kagawa, I Naito, Y Ueki, T Seki, R Momota, T Oohashi, ... The journal of biochemistry 123 (5), 767-776, 1998 | 177 | 1998 |
Mouse Cre models for the study of bone diseases SL Dallas, Y Xie, LA Shiflett, Y Ueki Current osteoporosis reports 16, 466-477, 2018 | 73 | 2018 |
SH3BP2 Cherubism Mutation Potentiates TNF‐α–Induced Osteoclastogenesis via NFATc1 and TNF‐α–Mediated Inflammatory Bone Loss T Mukai, S Ishida, R Ishikawa, T Yoshitaka, M Kittaka, R Gallant, YL Lin, ... Journal of Bone and Mineral Research 29 (12), 2618-2635, 2014 | 67 | 2014 |
Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism T Yoshitaka, T Mukai, M Kittaka, LM Alford, S Masrani, S Ishida, ... Cell reports 8 (6), 1752-1766, 2014 | 58 | 2014 |
Topoisomerase I and II consensus sequences in a 17-kb deletion junction of the COL4A5 and COL4A6 genes and immunohistochemical analysis of esophageal leiomyomatosis associated … Y Ueki, I Naito, T Oohashi, M Sugimoto, T Seki, H Yoshioka, Y Sado, ... The American Journal of Human Genetics 62 (2), 253-261, 1998 | 57 | 1998 |
Loss of SH3 Domain–Binding Protein 2 Function Suppresses Bone Destruction in Tumor Necrosis Factor–Driven and Collagen‐Induced Arthritis in Mice T Mukai, R Gallant, S Ishida, M Kittaka, T Yoshitaka, DA Fox, Y Morita, ... Arthritis & Rheumatology 67 (3), 656-67, 2015 | 48 | 2015 |
A gene for fluctuating, progressive autosomal dominant nonsyndromic hearing loss, DFNA16, maps to chromosome 2q23-24.3 K Fukushima, N Kasai, Y Ueki, K Nishizaki, K Sugata, S Hirakawa, ... The American Journal of Human Genetics 65 (1), 141-150, 1999 | 47 | 1999 |
Genomic structures of SCN2A and SCN3A–candidate genes for deafness at the DFNA16 locus N Kasai, K Fukushima, Y Ueki, S Prasad, J Nosakowski, K Sugata, ... Gene 264 (1), 113-122, 2001 | 46 | 2001 |
Structure of the human type XIX collagen (COL19A1) gene, which suggests it has arisen from an ancestor gene of the FACIT family M Khaleduzzaman, H Sumiyoshi, Y Ueki, K Inoguchi, Y Ninomiya, ... Genomics 45 (2), 304-312, 1997 | 44 | 1997 |
Pharmacological inhibition of tankyrase induces bone loss in mice by increasing osteoclastogenesis S Fujita, T Mukai, T Mito, S Kodama, A Nagasu, M Kittaka, T Sone, Y Ueki, ... Bone 106, 156-166, 2018 | 40 | 2018 |
Etanercept administration to neonatal SH3BP2 knock‐in cherubism mice prevents TNF‐α‐induced inflammation and bone loss T Yoshitaka, S Ishida, T Mukai, M Kittaka, EJ Reichenberger, Y Ueki Journal of Bone and Mineral Research 29 (5), 1170-1182, 2014 | 39 | 2014 |
Pro416Arg cherubism mutation in Sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties CJ Wang, IP Chen, B Koczon-Jaremko, AL Boskey, Y Ueki, L Kuhn, ... Bone 46 (5), 1306-1315, 2010 | 29 | 2010 |
Osteocytes directly regulate osteolysis via MYD88 signaling in bacterial bone infection T Yoshimoto, M Kittaka, AAP Doan, R Urata, M Prideaux, RE Rojas, ... Nature communications 13 (1), 6648, 2022 | 28 | 2022 |
SH3BP2 gain-of-function mutation exacerbates inflammation and bone loss in a murine collagen-induced arthritis model T Mukai, R Gallant, S Ishida, T Yoshitaka, M Kittaka, K Nishida, DA Fox, ... PloS one 9 (8), e105518, 2014 | 27 | 2014 |
Second‐generation SYK inhibitor entospletinib ameliorates fully established inflammation and bone destruction in the cherubism mouse model T Yoshimoto, T Hayashi, T Kondo, M Kittaka, EJ Reichenberger, Y Ueki Journal of Bone and Mineral Research 33 (8), 1513-1519, 2018 | 25 | 2018 |